Mineralys Therapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Mineralys Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q1 2022 to Q3 2024.
  • Mineralys Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -1.13 USD/shares, a 98.2% decline year-over-year.
  • Mineralys Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -3.26 USD/shares, a 4.15% decline year-over-year.
  • Mineralys Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.99 USD/shares, a 65.5% increase from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3 -$1 -$1 -98.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$3 -$1 -$1 -168% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$2 -$1 $0 -37.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$2 -$1 +$1.14 +65.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$3 -$1 +$0.72 +55.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$4 $0 +$0.95 +75.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$5 -$1 +$0.97 +65.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$6 -$2 Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$1 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$1 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$1 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.